Anatomical Heterogeneity in Low-grade and High-grade Gliomas: A Multiscale Perspective.

in NeuroImage by Shengpeng Liang, Nuo Dong, Yumin Chen, Yang Yang, Haibing Xu

TLDR

  • The study examined the spatial distribution of LGG and HGG and found that IDH-1 status, functional networks, and neurotransmitter systems contribute to anatomical heterogeneity.

Abstract

Low-grade gliomas (LGGs) and high-grade gliomas (HGGs) often exhibit distinct spatial distributions, a phenomenon that remains incompletely understood. Based on previous research, we hypothesized that functional networks, neurotransmitters, and isocitrate dehydrogenase-1 (IDH-1) status characterize the spatial patterns of LGG and HGG. We analyzed 399 patients diagnosed with primary gliomas. First, we generated glioma frequency maps based on tumor grade, neurotransmitters, and IDH-1 status and constructed a brain functional connectivity network to explore heterogeneity in glioma location. Second, all tumor masks were mirror-symmetrized onto the brain's left hemisphere to facilitate feature extraction. We performed independent component analysis on merged four-dimensional files using Multivariate Exploratory Linear Optimized Decomposition into Independent Component (MELODIC), identifying four IDH-1 wild-type lesion covariance networks (IDHwt-LCNs) and three IDH-1 mutant lesion covariance networks (IDHmut-LCNs) with distinct spatial distributions, and analyzing correlation between the neurotransmitter levels and the IDH-wt/mut specific LCNs. Finally, we compared 42 white matter fibers extracted using XTRACT with 39 functional brain connective networks from the multi-subject dictionary learning (MSDL) atlas, revealing significant associations among the frontal aslant tract (FAT) and the intraparietal sulcus (IPS). Our findings revealed high anatomical heterogeneity between LGG and HGG. Moreover, the high node strength played a critical role in the distinct spatial distribution of glioma. Significant correlations were observed between glioma frequency maps and dopaminergic, cholinergic, μ-opioid, and serotonergic neurotransmission. Furthermore, IDHwt/mut-LCNs analysis demonstrated that IDH-1 status influences glioma distribution, involving key brain structures. Lastly, we also found significant correlations between IDHwt/mut-LCNs and the neurotransmission of dopaminergic, cholinergic, μ-opioid, and serotonergic systems. Our study highlighted the mechanisms by which functional networks, neurotransmitter systems, and IDH-1 status collectively contribute to the anatomical heterogeneity observed in LGG and HGG.

Overview

  • The study aimed to explore the spatial distribution of low-grade gliomas (LGGs) and high-grade gliomas (HGGs) and identify factors influencing their anatomical heterogeneity.
  • The researchers analyzed 399 patients with primary gliomas, using functional networks, neurotransmitters, and IDH-1 status to understand the spatial patterns of LGG and HGG.
  • The primary objective was to determine the role of functional networks, neurotransmitter systems, and IDH-1 status in the anatomical heterogeneity of LGG and HGG.

Comparative Analysis & Findings

  • The study revealed high anatomical heterogeneity between LGG and HGG, with distinct spatial distributions influenced by IDH-1 status and functional networks.
  • Significant correlations were observed between glioma frequency maps and dopaminergic, cholinergic, μ-opioid, and serotonergic neurotransmission.
  • IDHwt/mut-LCNs analysis demonstrated that IDH-1 status influences glioma distribution, involving key brain structures.

Implications and Future Directions

  • The study highlights the importance of considering functional networks, neurotransmitter systems, and IDH-1 status when analyzing the anatomical heterogeneity of LGG and HGG.
  • Future research should investigate the specific mechanisms by which IDH-1 status influences glioma distribution and explore the potential therapeutic implications of these findings.
  • Further studies can utilize novel approaches to refine our understanding of the complex relationships between functional networks, neurotransmitter systems, and IDH-1 status in glioma development.